

Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds that may have applications for new disea⦠read more
Healthcare
Biotechnology
10 years
USD
Exclusive to Premium users
$8.31
Price+2.59%
$0.21
$467.810m
Small
17.7x
Premium
Premium
+5.6%
EBITDA Margin-5.4%
Net Profit Margin+15.9%
Free Cash Flow Margin$84.388m
+257.4%
1y CAGR+137.9%
3y CAGR+87.3%
5y CAGR$34.459m
+132.7%
1y CAGR-22.8%
3y CAGR-70.3%
5y CAGR$0.63
+127.6%
1y CAGR-4.8%
3y CAGR+12.2%
5y CAGR$133.165m
$270.116m
Assets$136.951m
Liabilities$62.717m
Debt23.2%
0.9x
Debt to EBITDA-$24.230m
+65.2%
1y CAGR-40.2%
3y CAGR-100.6%
5y CAGR